Home › Bipolar Disorder › Ohio
Bipolar Disorder clinical trials in Ohio
6 studies for Bipolar Disorder are looking for participants at sites in Ohio.
Cities in Ohio
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- University Of Cincinnati Medical Center /ID# 274160, Cincinnati
- The Ohio State University /ID# 272954, Columbus
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
- University of Cincinnati College of Medicine, Cincinnati
RecruitingMentions payment for participants
Ages 12 to 21 · All sexes · Updated Apr 22, 2026 · NCT06920940Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
- University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT03829787From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.